Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sam Roberts (Leeds, United Kingdom), Sam Roberts, Tim Sutherland, Jane Slough, Rhodri King, Robert Murray, Ian Clifton. Adrenal insufficiency in asthma patients – Who is at risk?. Eur Respir J 2016; 48: Suppl. 60, 4899

Member's Comments

No comment yet.

Related content which might interest you: Recurrent exacerbation of asthma: Characteristics of the patients and risk factors Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Risk factors of postoperative pulmonary complications in bronchial asthma and COPD patients Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Effects of beta-blockers on lung function in bronchial asthma patients Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Psychopathology in patients with bronchial asthma Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Comorbidity and some issues of cardiovascular disorders in disabled asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Risk factors for frequent exacerbations in (ex)smoking and never-smoking adult-onset asthma patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Effect of obesity and metabolic syndrome in patients with bronchial asthma Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Role of gastro-oesophageal reflux in severe asthma: Experience from the Wessex severe asthma cohort Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Influence of obesity and nasal polyps on severe asthma Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD) Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Anti-depressants in severe and brittle asthma patients on long term corticosteroids: An observational study Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Factors related with hospitalizations due to asthma exacerbations Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Comorbidity level in asthma patients Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Factors associated with irreversible airway obstruction in patients with asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Characteristics of essential hypertension in COPD patients Source: International Congress 2014 – COPD: points to ponder Year: 2014 Predictors of exacerbations in asthma Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Evaluation of arrhythmia frequency in patients with COPD Source: International Congress 2015 – Different data in COPD Year: 2015